Infusion Pump Global Market By Product Type, By Application, By Disease Indication, By End User, By Region, And Segment Forecasts, 2024-2033 | Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc.

The Infusion Pump by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Infusion Pump Market:
https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

According to The Business Research Company’s Infusion Pump, the infusion pump market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to aging population, chronic diseases, hospitalization trends, surgical procedures, advancements in healthcare.

The infusion pump market size is expected to see strong growth in the next few years. It will grow to $20.9 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to home healthcare trends, rise in ambulatory care centers, global health challenges, technological integration, patient empowerment. Major trends in the forecast period include development of wearable infusion devices, expansion of ambulatory infusion centers, customization for pediatric and geriatric patients, focus on cost-effectiveness and efficiency, integration of artificial intelligence in infusion systems..

The rise in the prevalence of chronic diseases is expected to propel the growth of the infusion pump market going forward. Chronic diseases refer to noncommunicable diseases (NCDs), which are long-term health conditions and often progress slowly over an extended period. The rise in the prevalence of chronic diseases, such as cancer and diabetes, is mostly driven by changing lifestyles, lack of physical activities, decreasing quality of life, and poor eating habits. Infusion pumps are used to treat some of these chronic diseases by providing accurate dosing, precise fluid delivery, and customized treatments. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there would be 142.66 million people with chronic diseases worldwide by the year 2050, up from 71.522 million in 2020. Also, the International Diabetes Federation, an organization of over 230 national diabetes associations in more than 160 countries and territories, projected that, there would be 643 million diabetics worldwide by 2030 and 783 million by 2045. Therefore, a rise in the prevalence of chronic diseases will fuel the infusion pump market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9968&type=smp

The infusion pump market covered in this report is segmented –
1) By Product: Accessories And Consumables, Devices
2) By Type: Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps
3) By Technology: Traditional Infusion Pumps, Specialty Infusion Pumps
4) By Application: Chemotherapy Or Oncology, Diabetes Management, Gastroenterology, Pain Management Or Analgesia, Pediatrics Or Neonatology, Hematology, Other Applications
5) By End User: Hospitals, Ambulatory Care Settings, Specialty Clinics, Home Care Settings

Technological advancement has emerged as a key trend gaining popularity in the infusion pump market. Major companies operating in the infusion pump market are focused on developing new technological solutions to strengthen their position. For instance, in November 2022, US-based medical device company Medtronic launched the world’s first and only insulin pump infusion set, MiniMed Quick-set Plus. It was uniquely developed with cutting-edge components that aid in lowering insulin preservative loss and maintaining insulin flow and stability to extend an infusion set’s wear time by two times. It is the first and only infusion set that is approved by FDA, and it is designed to provide a more convenient and comfortable experience for diabetes patients.

The infusion pump market report table of contents includes:
1. Executive Summary